Bay Colony Advisory Group, Inc D Crispr Therapeutics Ag Transaction History

Bay Colony Advisory Group, Inc D

$643 Million
Q4 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	SELL	$51.17 - $68.18 $9,517 - $12,681	-186 Reduced 4.46%	3,989 $215,000
Q1 2024 Apr 30, 2024	SELL	$60.67 - $89.12 $45,987 - $67,552	-758 Reduced 15.37%	4,175 $284,000
Q4 2023 Jan 29, 2024	SELL	$38.62 - $72.18 $75,309 - $140,751	-1,950 Reduced 28.33%	4,933 $308,000
Q3 2023 Nov 13, 2023	SELL	$45.39 - $59.0 $5,673 - $7,375	-125 Reduced 1.78%	6,883 $312,000
Q2 2023 Aug 11, 2023	SELL	$43.47 - $67.77 $2,695 - $4,201	-62 Reduced 0.88%	7,008 $393,000
Q1 2023 Apr 27, 2023	SELL	$41.0 - $56.12 $4,100 - $5,612	-100 Reduced 1.39%	7,070 $319,000
Q4 2022 Feb 01, 2023	SELL	$39.19 - $65.67 $7,838 - $13,134	-200 Reduced 2.71%	7,170 $291,000
Q2 2022 Aug 08, 2022	BUY	$43.23 - $73.83 $69,168 - $118,128	1,600 Added 27.73%	7,370 $553,000
Q1 2022 Apr 28, 2022	BUY	$53.19 - $79.24 $26,488 - $39,461	498 Added 9.45%	5,770 $362,000
Q4 2021 Jan 28, 2022	BUY	$70.09 - $111.29 $91,187 - $144,788	1,301 Added 32.76%	5,272 $400,000
Q3 2021 Nov 02, 2021	SELL	$110.2 - $156.64 $3,085 - $4,385	-28 Reduced 0.7%	3,971 $444,000
Q1 2021 May 13, 2021	BUY	$110.72 - $210.04 $158,218 - $300,147	1,429 Added 55.6%	3,999 $487,000
Q4 2020 Feb 02, 2021	SELL	$79.67 - $173.23 $97,595 - $212,206	-1,225 Reduced 32.28%	2,570 $393,000
Q3 2020 Nov 25, 2020	BUY	$78.5 - $100.64 $58,482 - $74,976	745 Added 24.43%	3,795 $317,000
Q2 2020 Jul 23, 2020	BUY	$38.5 - $76.05 $117,425 - $231,952	3,050 New	3,050 $224,000
Q1 2020 Apr 17, 2020	SELL	$33.68 - $62.53 $133,036 - $246,993	-3,950 Closed	0 $0
Q4 2019 Jan 28, 2020	BUY	$36.68 - $73.13 $144,886 - $288,863	3,950 New	3,950 $231,000
Q4 2019 Jan 28, 2020	SELL	$36.68 - $73.13 $181,566 - $361,993	-4,950 Closed	0 $0
Q2 2019 Jul 17, 2019	SELL	$35.45 - $48.2 $33,677 - $45,790	-950 Reduced 16.1%	4,950 $233,000
Q1 2019 Apr 30, 2019	BUY	$28.02 - $40.87 $165,318 - $241,132	5,900 New	5,900 $206,000

Others Institutions Holding CRSP

# of Institutions

484

Shares Held

64.1M

Call Options Held

1.64M

Put Options Held

1.93M

Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

8.97M
Shares

$453 Million
3.09% of portfolio
Capital International Investors Los Angeles, CA

8.74M
Shares

$441 Million
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

3.81M
Shares

$192 Million
0.09% of portfolio
Black Rock Inc. New York, NY

2.78M
Shares

$140 Million
0.0% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

2.75M
Shares

$138 Million
0.07% of portfolio

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.93B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bay Colony Advisory Group, Inc D, based on Form 13F filings with the SEC.

News

Stay updated on Bay Colony Advisory Group, Inc D with notifications on news.

Account